PATENT CLAIM ANALYSIS

Application Number: 16260350
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["514", "359000"]

Abstract:
The present invention provides a compound represented by formula ( 1 ): or pharmaceutically acceptable salt thereof, wherein X and Y are the same or different from each other and represent a hydrogen atom, a halogen atom, a C 1-6  alkyl group, or a C 1-6  alkoxy group, wherein the C 1-6  alkoxy group may be substituted with a C 1-6  alkoxy group, and Z and W are the same or different from each other and represent a hydrogen atom, a halogen atom, or a C 1-6  alkyl group.

Claim (Index 10):
2,6-dichloro-N-{[4-(methoxymethyl)-3-methylphenyl]methyl}benzamide represented by the formula: or a pharmaceutically acceptable salt thereof according to  claim 1 .

Metadata:
- Claim Count in Document: 14.0
- Percentile: 99.0
- Lexical Diversity: 2.15217
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13237205', '14190356', '13819881', '14577660', '13609716']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.79746563079523
- 35 USC 102 Novelty (BERT): 0.5182432226906346
- Combined Prediction Score: 0.7695433899847705
- Mean Citation Score: 305.704242
- Max Citation Score: 327.20746
- Similarity Product: 285.6547734248137

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test